Skip to main content
OpenTrials

Clinical trial condition

Refractory Secondary Acute Myeloid Leukemia

Explore clinical trials studying Refractory Secondary Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Refractory Secondary Acute Myeloid Leukemia trial results

Recruiting

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03874052

Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States
View Trial Details
Not Yet Recruiting

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

NCT07582172

Conditions
Acute Myeloid Leukemia With Complex Karyotype, Bone Marrow Diseases, Hematologic Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
View Trial Details

Related conditions